Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

8.92

+0.77 (9.45%)

At close: Feb 6, 2026, 4:00 PM EST

8.88

-0.04 (-0.47%)

After-hours: Feb 6, 2026, 7:59 PM EST

Relay Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,546	690	1,357	1,806	3,318	3,733
Market Cap Growth	88.89%	-49.19%	-24.86%	-45.56%	-11.11%	-
Enterprise Value	983	-100	601	813	2,725	3,043
Last Close Price	8.92	4.12	11.01	14.94	30.71	41.56
PS Ratio	181.61	68.91	53.13	1307.87	1095.42	45.16
PB Ratio	2.53	0.89	1.81	1.90	3.70	4.89
P/TBV Ratio	2.54	0.89	1.81	1.91	3.71	4.89
EV/Sales Ratio	117.65	-	23.53	588.46	899.58	36.82
Debt / Equity Ratio	0.06	0.06	0.07	0.06	0.03	0.03
Asset Turnover	0.01	0.01	0.03	0.00	0.00	0.14
Quick Ratio	18.29	15.40	24.78	15.76	39.60	55.80
Current Ratio	19.14	15.95	25.44	16.00	40.14	56.49
Return on Equity (ROE)	-41.14%	-44.15%	-40.18%	-31.44%	-43.81%	-9.35%
Return on Assets (ROA)	-25.37%	-28.11%	-24.40%	-18.44%	-15.63%	-5.85%
Return on Capital Employed (ROCE)	-51.00%	-47.00%	-46.60%	-30.00%	-23.00%	-7.10%
Earnings Yield	-19.25%	-48.97%	-25.20%	-16.08%	-10.97%	-1.40%
FCF Yield	-16.10%	-36.41%	-22.43%	-13.21%	-2.35%	-2.80%
Buyback Yield / Dilution	-28.69%	-16.55%	-9.21%	-17.97%	-123.22%	-1135.17%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q